Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Stark

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Plos One|December 10, 2020
Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approachDan Kajungu, Michael Muhoozi, James Stark, et al.
Pediatrics|May 3, 2002
Chronic lung disease after activated charcoal aspirationGavin R Graff, James Stark, John W Berkenbosch, et al.
Scientific Reports|January 23, 2025
Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022Andreas Palmborg, Frederick J Angulo, Pingping Zhang, et al.
Ebiomedicine|February 17, 2018
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple SclerosisViolaine K Harris, James Stark, Tamara Vyshkina, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 18, 2023
Estimated Number of Symptomatic Lyme Borreliosis Cases in Adults in Finland in 2021 Using Seroprevalence Data to Adjust the Number of Surveillance-Reported Cases: A General Framework for Accounting for Underascertainment by Public Health SurveillanceJulia Olsen, Frederick J Angulo, Andreas Pilz, et al.
Shock (Augusta, Ga.)|February 12, 2002
Heat shock inhibits tnf-induced ICAM-1 expression in human endothelial cells via I kappa kinase inhibitionGary Kohn, Hector R Wong, Khaled Bshesh, et al.
Advances in Therapy|June 17, 2026
Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative ReviewPiero Barbanti, Timothy Smith, Verena Ramirez Campos, et al.
Plos Currents|March 2, 2012
Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 InfluenzaTed Ross, Shanta Zimmer, Don Burke, et al.
The Open Respiratory Medicine Journal|July 17, 2018
Characteristics and Outcomes of Children with Clinical History of Atopic <i>Versus</i> Non-atopic Asthma Admitted to a Tertiary Pediatric Intensive Care UnitJamie Causey, Traci Gonzales, Aravind Yadav, et al.
Ticks and Tick-Borne Diseases|November 16, 2025
Seroprevalence of Borrelia burgdorferi sensu lato and incidence of Lyme borreliosis in SwitzerlandRahel Ackermann-Gäumann, Christoph Niederhauser, Peter Gowland, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Plos One|December 10, 2020
Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approachDan Kajungu, Michael Muhoozi, James Stark, et al.
Pediatrics|May 3, 2002
Chronic lung disease after activated charcoal aspirationGavin R Graff, James Stark, John W Berkenbosch, et al.
Scientific Reports|January 23, 2025
Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022Andreas Palmborg, Frederick J Angulo, Pingping Zhang, et al.
Ebiomedicine|February 17, 2018
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple SclerosisViolaine K Harris, James Stark, Tamara Vyshkina, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 18, 2023
Estimated Number of Symptomatic Lyme Borreliosis Cases in Adults in Finland in 2021 Using Seroprevalence Data to Adjust the Number of Surveillance-Reported Cases: A General Framework for Accounting for Underascertainment by Public Health SurveillanceJulia Olsen, Frederick J Angulo, Andreas Pilz, et al.
Shock (Augusta, Ga.)|February 12, 2002
Heat shock inhibits tnf-induced ICAM-1 expression in human endothelial cells via I kappa kinase inhibitionGary Kohn, Hector R Wong, Khaled Bshesh, et al.
Advances in Therapy|June 17, 2026
Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative ReviewPiero Barbanti, Timothy Smith, Verena Ramirez Campos, et al.
Plos Currents|March 2, 2012
Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 InfluenzaTed Ross, Shanta Zimmer, Don Burke, et al.
The Open Respiratory Medicine Journal|July 17, 2018
Characteristics and Outcomes of Children with Clinical History of Atopic <i>Versus</i> Non-atopic Asthma Admitted to a Tertiary Pediatric Intensive Care UnitJamie Causey, Traci Gonzales, Aravind Yadav, et al.
Ticks and Tick-Borne Diseases|November 16, 2025
Seroprevalence of Borrelia burgdorferi sensu lato and incidence of Lyme borreliosis in SwitzerlandRahel Ackermann-Gäumann, Christoph Niederhauser, Peter Gowland, et al.
Pageof 5